Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Research & Development (2020 - 2025)

Sanara MedTech's Research & Development history spans 6 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Research & Development rose 130.44% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $5.4 million, up 51.06%, while the annual FY2025 figure was $5.1 million, 79.32% up from the prior year.
  • Research & Development reached $2.0 million in Q4 2025 per SMTI's latest filing, up from $1.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.0 million in Q4 2025 to a low of $35674.0 in Q3 2021.
  • Average Research & Development over 5 years is $854714.6, with a median of $986052.5 recorded in 2023.
  • Peak YoY movement for Research & Development: skyrocketed 2875.24% in 2022, then crashed 36.99% in 2023.
  • A 5-year view of Research & Development shows it stood at $300837.0 in 2021, then soared by 243.71% to $1.0 million in 2022, then plummeted by 36.99% to $651519.0 in 2023, then skyrocketed by 35.59% to $883400.0 in 2024, then soared by 130.44% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Research & Development are $2.0 million (Q4 2025), $1.0 million (Q3 2025), and $1.3 million (Q2 2025).